3 ASX stocks hitting 52-week lows — is this the bottom?

Do beat-up companies like Codan, The Reject Shop, and Lynas Corporation belong in the bargain basket, or the bin?

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Poor results from  Codan (ASX: CDA) have seen its share price plunge nearly 80% since a profit downgrade in June last year, while The Reject Shop (ASX: TRS) is down nearly 50% since January after its half-year trading update saw major shareholders sell out. Lynas Corporation (ASX: LYC) returns again for the third week running as shareholders twig to the unsustainability of its current operations.

1. Codan

Codan is currently trading around $0.615, down about 83% in the last year.

All four of Codan's revenue streams for the December half of 2013 were significantly lower than the same half in 2012 and shareholders have abandoned the company in droves, sending its share price spiraling downwards. Codan's profit margins have also shrunk as a result of fewer sales of high-margin gold detection equipment, which was itself caused by weaker demand.

Codan has maintained its investment levels in new products in order to bring new products to market quicker, but I don't know if that will be enough to turn this company's fortunes around. Gold demand looks likely to remain subdued for the foreseeable future, particularly as global production rises and U.S. quantitative easing winds down (the price of gold often rises during periods of loose monetary policy).

I was also concerned by a line in the half-yearly accounts regarding a rise in Codan's total borrowings: "The payment of the final dividend and tax liabilities from the record FY13 year were major contributors to the increase in borrowings."

I would hope this doesn't mean that Codan is paying its dividends with debt; particularly given its financial future is considerably less glossy than it was 18 months ago. Bearing all this I mind, I recommend investors steer clear of this company for the moment.

The Reject Shop

The Reject Shop is trading around $8.95, down about 45% in the last year.

Despite growing revenue by 17.7% in the first half of last year, The Reject Shop disappointed investors with flat comparable store sales and a net profit attributable to members figure that was down 15.9% on the prior corresponding period (almost entirely due to a $2 million insurance payout and increased costs associated with new store openings).

Major shareholders responded by jumping ship en masse, with Australian Super, Swiss bank UBS AG, and Commonwealth Bank of Australia completely selling out. All in all it looks like around 15% of The Reject Shop's shares were sold in a short space of time, which is no doubt responsible for the plummet in share price. Curiously, Commonwealth Bank and UBS only became substantial holders mere days before the negative trading update, which leads me to believe they were expecting much better results than were announced.

I suspect that UBS and Commonwealth both lost considerable chunks of money during their short tenure as shareholders, and ultimately their actions created opportunities for fund managers Clime Investment Management to jump on board with a 5.38% share in the company, and Westpac subsidiary BT Super to increase its stake by 1.2% to 9.99%. Shrewd retail investors also have a golden opportunity to get in on the action, because The Reject Shop's results were nowhere near as disappointing as a 47% drop in share price would indicate.

Lynas Corporation

Lynas Corporation's stock is trading at $0.18, down 69% in the last year.

Lynas has dropped another 25% in the last two weeks as investors pull their money out of the stock. Those who are still holding may want to look at doing the same within the next month or so — if not immediately — because any loss is better than a total loss. For a full overview of the woes plaguing Lynas Corporation, see Mike King's recent article, "Is Lynas Corporation peering into the abyss?".

Foolish takeaway

Codan and Lynas are companies to avoid for the time being, but investors would do well to add The Reject Shop to their watchlist. Future store margins and sales results will be crucial to the its success, and a falling Australian dollar has the potential to eat into profits, but if you are a believer in the business I very much doubt if you will see a better time or price to buy into The Reject Shop.

Motley Fool contributor Sean O’Neill doesn’t own shares in any company listed. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »